TS Financial Group (TSFG)’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-109
Closed -$1K 948
2023
Q4
$1K Buy
109
+9
+9% +$58 ﹤0.01% 865
2023
Q3
$1K Hold
100
﹤0.01% 1036
2023
Q2
$1K Hold
100
﹤0.01% 978
2023
Q1
$1K Hold
100
﹤0.01% 946
2022
Q4
$2K Hold
100
﹤0.01% 869
2022
Q3
$1K Hold
100
﹤0.01% 938
2022
Q2
$2K Hold
100
﹤0.01% 853
2022
Q1
$3K Hold
100
﹤0.01% 752
2021
Q4
$3K Hold
100
﹤0.01% 736
2021
Q3
$5K Hold
100
﹤0.01% 668
2021
Q2
$5K Hold
100
﹤0.01% 662
2021
Q1
$6K Hold
100
﹤0.01% 578
2020
Q4
$5K Hold
100
﹤0.01% 615
2020
Q3
$5K Hold
100
﹤0.01% 565
2020
Q2
$6K Sell
100
-150
-60% -$9.08K ﹤0.01% 526
2020
Q1
$10K Hold
250
0.01% 387
2019
Q4
$12K Hold
250
0.01% 403
2019
Q3
$11K Hold
250
0.01% 401
2019
Q2
$11K Hold
250
0.01% 395
2019
Q1
$13K Buy
+250
New +$12.5K 0.01% 361

Other funds holding ORGS

TS Financial Group (TSFG)'s ORGS Position: Q1 2024 in Review

TS Financial Group (TSFG) sold out of Orgenesis Inc. Common Stock (ORGS) in Q1 2024, closing a stake of 109 shares — an estimated $1K sold.

TS Financial Group (TSFG) first reported a position in ORGS in Q1 2019 and held it in 20 quarters. The position peaked at $13K in Q1 2019. 16 funds tracked by Wall St. Rank hold ORGS as of Q1 2024.

  • TS Financial Group (TSFG) reported no remaining Orgenesis Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 109 Orgenesis Inc. Common Stock shares in Q1 2024, an estimated $1K.
  • TS Financial Group (TSFG) first reported a position in Orgenesis Inc. Common Stock in Q1 2019 and held it in 20 quarters.
  • TS Financial Group (TSFG)'s Orgenesis Inc. Common Stock position peaked at $13K in Q1 2019.
  • 16 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q1 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2024, filed 16 Apr 2024.